NAVIFUS CORPORATION
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
1. NaviFUS® Neuronavigator-guided transcranial focused ultrasound system
2. NAVIRFA® Needle Tracking System
2. NAVIRFA® Needle Tracking System
The content above was translated by Ai
Founded Year
2015
Unified Business No.
24731239
Status
Active
Number of Employees
0
Total Paid-in
Capital
707,505,110 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2022)、OTC listing(2025)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
As a biotech company, NaviFUS provides novel platform solutions for enhancing the delivery of oncology drugs across the blood-brain barrier. The company's product NaviFUS System utilizes non-invasive ultrasound energy, the NaviFUS System increases BBB permeability transiently and safely, facilitating targeted delivery of small or largemolecular CNS drugs. The company's focus is on helping CNS disease patients globally by supplying therapeutic ultrasound technologies for clinical use through partnerships with global pharmaceutical companies.
The content above was translated by Ai
